NEW YORK (GenomeWeb) – Bio-Reference Laboratories today said that its fiscal first quarter revenues grew 15 percent year over year but missed the average analysts' estimates on the top and bottom lines.

For the three months ended Jan. 31, Bio-Reference recorded $208.8 million in revenues, up from $181.3 in the year-ago first quarter, but below the consensus Wall Street estimate of $216 million. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.